argenx ir biotehnoloģiju uzņēmums, kas koncentrējas uz imunoloģiju un izstrādā uz antivielām balstītus ārstēšanas līdzekļus smagām autoimūnām slimībām. Tā pētniecībā apvienojas iekšējās komandas, vadošie zinātnieki un akadēmiskie sadarbības partneri, lai identificētu terapeitiskas antivielas, kas iedarbojas uz konkrētiem slimības mehānismiem. Uzņēmuma darbs ietver efgartigimoda izstrādi slimībām, kuru attīstībā nozīme ir patogēnām IgG antivielām, koncentrējoties uz pacientiem un nozīmīgu medicīnisku ārstēšanas iespēju pilnveidi.
Global Pricing Director, Developed Markets
Lead launch and lifecycle pricing for argenx autoimmune medicines, with a focus on Germany and developed markets. Shape market access, reimbursement and sustainable pricing strategies.
Apraksts
- Develop global pricing strategies for upcoming launches, pipeline assets and lifecycle opportunities, with a focus on Germany and developed markets.
- Set launch pricing frameworks, price corridors and strategic guidance.
- Turn global pricing strategy into practical plans, policies and implementation guidance.
- Align stakeholders and integrate pricing decisions into launch readiness and execution plans.
- Work with country teams on local pricing and reimbursement strategies.
- Evaluate International Reference Pricing risks, launch sequencing and cross-market price dependencies.
- Build pricing assumptions, scenario analyses and long-term revenue projections with finance and forecasting teams.
- Support business cases for launches, reimbursement, market entry and access.
- Track external pricing, reimbursement, policy and competitive developments.
- Help maintain global pricing governance and transparent decision-making.
- Create and maintain pricing tools, frameworks and guidance.
- Oversee external vendors, consultants and partners.
- Build cross-functional partnerships and advise global, regional and country leaders.
- Strengthen pricing capabilities and contribute to a collaborative, delivery-focused team.
Prasības
- Bring at least 10 years of relevant experience in biotechnology, pharmaceuticals or healthcare.
- Have at least 8 years of experience in global pricing, market access and reimbursement.
- Demonstrate deep knowledge of pharmaceutical pricing, market access and reimbursement strategy across global HTA markets.
- Show a record of developing and delivering launch pricing strategies for specialty medicines, rare diseases and innovative therapies.
- Understand International Reference Pricing, launch sequencing, pricing governance and global market dynamics.
- Use data and scenario analysis to make structured decisions.
- Influence senior stakeholders in a complex, global matrix organization.
- Communicate and present effectively.
- Demonstrate project management capability.
- Have a strong grasp of German market access; this is strongly preferred.
- Bring experience in rare disease, specialty care, immunology or another highly specialized therapeutic area; this is strongly preferred.
- Have led or made a substantial contribution to pricing strategy for global product launches.
- Show success influencing strategic decisions and delivering pricing recommendations across major markets.
- Have advanced graduate-level training in natural sciences, medicine, business, finance, health economics, public policy or a related field; this is preferred.
- Be fluent in English; additional languages are an advantage.
- Be available for regular international travel.
Priekšrocības
- Competitive salary and comprehensive benefits.
- Short-term incentive program.
- Long-term incentive program.
- Equal-opportunity, inclusive workplace.